Global Formulation Development Services Market Growth (Status and Outlook) 2025-2031

The global Formulation Development Services market size is predicted to grow from US$ 9937 million in 2025 to US$ 14440 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.

Formula development service refers to a professional service that customizes and optimizes product formulas for customers through scientific research and experiments. It covers the entire process from raw material selection, ingredient ratio adjustment to production process optimization, aiming to meet customers' specific needs for product function, performance, safety and cost. Formula development services are widely used in many industries such as cosmetics, food, pharmaceuticals, cleaning products, chemical products, etc., helping customers develop innovative products with market competitiveness. Through professional formula development services, companies can improve product quality, reduce production costs, and respond quickly to market demand.

United States market for Formulation Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Formulation Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Formulation Development Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Formulation Development Services players cover Coriolis Pharma, Aurigene Pharmaceutical Services, Adragos Pharma, Ascendia Pharmaceuticals, Dalton Pharma Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Formulation Development Services Industry Forecast” looks at past sales and reviews total world Formulation Development Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Formulation Development Services sales for 2025 through 2031. With Formulation Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Formulation Development Services industry.

This Insight Report provides a comprehensive analysis of the global Formulation Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Formulation Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Formulation Development Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Formulation Development Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Formulation Development Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Formulation Development Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Food and Beverage Formula Development
Drug Formula Development
Cosmetic Formula Development
Health Care Product Formula Development
Others

Segmentation by Application:
Large Enterprises
Small and Medium Enterprises

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Coriolis Pharma
Aurigene Pharmaceutical Services
Adragos Pharma
Ascendia Pharmaceuticals
Dalton Pharma Services
Intertek
Suven Pharma
Agno Pharma
SGS SA
DPT Laboratories Ltd
MedPharm
Octavius Pharma
Pharmaron
CuriRx, Inc.
LGM pharma
Avivia BV
Corealis
Losan Pharma
Evonik Health Care
Lonza
Alcami
Scantox

Please note: The report will take approximately 2 business days to prepare and deliver. Show more